Prabodh Mathur - Chief Product Development Officer

Mr. Mathur joined Vessix in September 2010. Mr. Mathur is a seasoned technical executive with a proven track record of developing complex, innovative, Class III medical devices from concept, through design exploration, IP review, engineering, manufacturing transfer, regulatory clearance to market launch. Mr. Mathur held numerous engineering leadership positions, including chief technical officer, with Cardiac Science over a 15 year period until 2009. Earlier, Mr. Mathur was, for nine years, vice president of engineering of Medstone International, a manufacturer of transportable lithotripters. Over the past years, Mathur has been involved in developing products that include a catheter-based biopolymer delivery system, fully automatic public-access defibrillators, multi-parameter patient monitor, lithotripters, cryoablation delivery systems, and industrial high-power carbon dioxide laser and robotic system. Cumulative revenues from products designed under his leadership exceed $1 billion. Mr. Mathur holds a M.S. in Engineering from Missouri University of Science and Technology and a B.S. in Mechanical Engineering from Indian Institute of Technology in Kanpur, India. 

Dan L. Dearen - Chief Operating & Financial Officer

Mr. Dearen joined Vessix in 2010. For nearly 25 years, Mr. Dearen has been involved in the financial and strategic management of companies in the medical and technology industries. Prior to joining Vessix, Mr. Dearen served as CFO for Miraval Holding, Q3DM, Fairbanks Systems Group and Medication Delivery Devices. Previously, Mr. Dearen was a director for Ventana Growth Funds, an international venture capital firm with 53 portfolio companies in the medical device, biotechnology and healthcare service sectors. Mr. Dearen began his career as a CPA in the healthcare group for Ernst & Young. Mr. Dearen holds an MBA from Boston College and a BBA from Southern Methodist University.

Michael D. Gioffredi - Chief Commercialization Officer

Mr. Gioffredi joined Vessix in April 2012. For over 25 years, Mr. Gioffredi has been a sales and marketing executive in the medical device industry. Prior to joining Vessix, and for the past 6 years, Mr. Gioffredi served as Sr. VP of Sales and Marketing for Angioscore, Inc, a manufacturer of balloon catheter technology for use in peripheral and coronary arteries. Previously, Mr. Gioffredi was the Chief Marketing Officer for Cardiac Science Inc., where he worked directly with Vessix's CEO to position the Company as the 4th fastest growing technology company in North America on Deloitte and Touche's Fast 500 listing. He began his career with Pfizer and spent ten years at Bard (USCI). Mr. Gioffredi holds an B.A. in Business Administration from California State University at Fullerton.

Henry Hauser - Vice President, Clinical Affairs

Mr. Hauser joined Vessix in March of 2012. Mr. Hauser has over 25 years of experience in medical devices and services, including 13 years of clinical research experience in therapeutic areas of cardiology and aesthetic medicine.  Prior to joining Vessix, Mr. Hauser was Director of Clinical Affairs for Ulthera, Inc., an aesthetic medical device company where he was responsible for clinical trials (n=1100). Mr. Hauser has been responsible for running clinical pilot and pivotal studies in Europe and the US for early stage companies (Sub-Q, TherOx, and Rubicon) and larger organizations such as Boston Scientific. Mr. Hauser began his career and spent almost a decade in cardiac cath labs in southern California as a cardiovascular specialist responsible for performing over 3000 procedures per year. Mr. Hauser earned his Bachelors of Science in Radiology from the University of Oklahoma Health Sciences Center.

Meital Mazor, Ph.D. - Senior Director, Clinical Research

Dr. Mazor joined Vessix in 2008. For nearly 10 years, Dr. Mazor has been working in the field of vascular diseases and has gained experience in experimental designs and clinical studies. Prior to joining Vessix she led pre-clinical studies for Shire, a pharma company, where she focused on treatments chronic renal failure patients. Dr. Mazor received her Ph.D. in Medical Sciences as well as her MBA from from the Technion-Israel institute of technology.